Cargando…
Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
Tafenoquine is a highly effective treatment for Babesia microti infections in animal models. An immunocompromised patient infected by a strain of B. microti that was at least partially resistant to both azithromycin and atovaquone was treated with tafenoquine. Systematic clinical studies using tafen...
Autores principales: | Marcos, Luis A., Leung, Annie, Kirkman, Laura, Wormser, Gary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885462/ https://www.ncbi.nlm.nih.gov/pubmed/35242564 http://dx.doi.org/10.1016/j.idcr.2022.e01460 |
Ejemplares similares
-
Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone
por: Kletsova, Ekaterina A., et al.
Publicado: (2017) -
Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections
por: Marcos, Luis A, et al.
Publicado: (2023) -
Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs
por: Kirk, S.K., et al.
Publicado: (2017) -
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone
por: Lawres, Lauren A., et al.
Publicado: (2016) -
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)